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Abstract 1-Cys peroxiredoxin (1-cysPrx), a member of the
peroxiredoxin family with a single conserved cysteine, is a
unique antioxidant enzyme. We have generated mice in which
the 1-cysPrx gene has been inactivated; they are viable and
fertile. Mice have a highly related intronless gene (1-cysPrx-
P1, GenBank accession number AF085220) with the same
length of open reading frame (224 aa) as 1-cysPrx but located
on a di¡erent chromosome. Since the product of this gene pos-
sibly could mimic 1-cysPrx function, we compared expression of
1-cysPrx and 1-cysPrx-P1 in mouse tissues by real-time poly-
merase chain reaction and Western blot. 1-cysPrx mRNA and
protein were expressed in all mouse tissues that were examined
with the highest expression level in lung. 1-cysPrx-P1 mRNA
was expressed only in testis. In the 1-cysPrx ‘knock-out’ mouse,
1-cysPrx-P1 mRNA expression level was similar to the wild
type but protein expression was not detected. Thus, mouse
1-cysPrx-P1 is an mRNA-expressed pseudogene that does not
result in detectable protein in vivo.
6 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
1-Cys peroxiredoxin (1-cysPrx) is a unique member of the
peroxiredoxin family of antioxidant enzymes that contains a
single conserved cysteine [1] and uses glutathione as the phys-
iological reductant [2]. This protein has both glutathione per-
oxidase and phospholipase A2 activities [2] and can reduce
phospholipid hydroperoxides [3]. Altered expression of
1-cysPrx has been shown in several human diseases including
malignant mesothelioma [4] and in a mouse model of al-
tered susceptibility to atherosclerosis [5]. Overexpression of
1-cysPrx can protect cells against phospholipid peroxidation-
mediated membrane damage [6] while lipid peroxidation and
apoptosis occur when expression is blocked by treatment with
an antisense oligonucleotide to 1-cysPrx [7].
Since the 1-cysPrx enzyme appears to play a key role in
antioxidant defense, deleting the expression of this gene is
expected to result in manifestations of oxidative stress. On
the other hand, alternative antioxidant defense pathways
might compensate for 1-cysPrx inactivation. A mouse with
an inactivated 1-cysPrx gene was generated in order to study
this question. A potential limitation to the study of 1-cysPrx
function is the recent detection of two intronless murine
genes, 1-cysPrx-P1 and 1-cysPrx-P2 (GenBank accession num-
bers AF085220 and AF085221, respectively), that show high
similarity to 1-cysPrx [8,9]. 1-cysPrx-P1 and 1-cysPrx-P2 are
located on mouse chromosomes 2 and 4, respectively [9], while
1-cysPrx is located on mouse chromosome 1 [10]. Alignment
of the cDNA sequences for these intronless genes with the
open reading frame (ORF) sequence of 1-cysPrx revealed
V93% and V80% identity, respectively [9]. 1-cysPrx-P2 con-
tains a disrupted ORF that would result in a truncated pro-
tein that is only 119 amino acids long and would not be
expected to exhibit peroxidase activity. On the other hand,
1-cysPrx-P1 shows an intact ORF (224 amino acids) with
86% identity to 1-cysPrx [9]. Inspection of its upstream se-
quence suggests that it would be di¡erentially regulated as
compared to 1-cysPrx [9]. Whether 1-cysPrx-P1 protein is ex-
pressed in vivo and its properties are unknown. Of practical
importance, expression of 1-cysPrx-P1 protein could compli-
cate studies with 1-cysPrx knock-out mice.
In this study, we inactivated the 1-cysPrx gene in embryonic
stem (ES) cells, used the cells to develop mice that were het-
erozygous for the inactivated gene and then bred them to
produce homozygous 1-cysPrx null mice. We used real-time
polymerase chain reaction (PCR) to compare the expression
levels of 1-cysPrx and 1-cysPrx-P1 in various mouse tissues,
studied immunoreactivity of protein expressed by the
1-cysPrx-P1 ORF, and used the 1-cysPrx knock-out mouse
to investigate 1-cysPrx-P1 protein expression in vivo. Our
study suggests that mouse 1-cysPrx-P1 is an mRNA-expressed
pseudogene that does not result in detectable protein in vivo.
2. Materials and methods
2.1. Chemicals and reagents
All primers were synthesized by Qiagen (Valencia, CA, USA).
JumpStart1 REDTaq1 DNA polymerase and Deoxynucleotide
Mix were obtained from Sigma Chemical Co. (Saint Louis, MO,
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USA). Isopropyl-1-thio-L-D-galactopyranoside (IPTG) and 5-bromo-
4-chloro-3-indolyl-L-D-galactoside (X-gal) were purchased from Fisher
Scienti¢c (Pittsburgh, PA, USA). IPTG (100 mM) was prepared in
sterile H2O. X-gal was prepared 20 mg/ml in dimethylformamide.
Restriction endonucleases were from New England Biolabs (Beverly,
MA, USA). DNA molecular markers, T4 DNA ligase, and Wizard
Plus SV Minipreps DNA Puri¢cation System were from Promega
(Madison, WI, USA). XL10-Gold Ultracompetent Cells were from
Stratagene (La Jolla, CA, USA). Shrimp alkaline phosphatase was
from Roche (Indianapolis, IN, USA). All other biological reagents,
except those noted otherwise, were purchased from Invitrogen (Carls-
bad, CA, USA). All chemicals and reagents were used as received.
2.2. Generation of 1-cysPrx knock-out mice and animal care
The previously described BAC genomic clone (clone BACM-
153C17 from a 129/SvJ mouse genomic library), which contains the
entire functional 1-cysPrx gene [8], was initially obtained from Ge-
nome Systems (St. Louis, MO, USA) and used to construct the tar-
geting vector. Brie£y, the EcoRI genomic fragment containing exons 1
and 2 was cloned into the EcoRI site of plasmid pPNT [11], kindly
provided by Dr. R. Mulligan of Harvard University, with the orien-
tation of transcription opposite that of the neomycin resistance cas-
sette (neo) and the herpes simplex virus thymidine kinase (TK) gene
(Fig. 1A). The BamHI-HindIII genomic fragment spanning from part
of exon 3 to part of exon 5 was initially modi¢ed to remove the
BamHI restriction site and then inserted into the XhoI site of plasmid
pPNT. The targeting vector was linearized with the restriction enzyme
NotI and transfected into R1 mouse ES cells [12], kindly provided by
Dr. A. Nagy (Mount Sinai Hospital, Toronto, ON, Canada). The
transfected ES cells were selected in medium containing 300 Wg/ml
of G418 and 2 WM ganciclovir (a gift from Syntex, Palo Alto, CA,
USA). Colonies resistant to both drugs were screened by Southern
blot analysis using a 0.2 kb EcoRI genomic fragment which is external
to the genomic sequence in the targeting vector. Using this probe, the
signal from the endogenous mouse 1-cysPrx gene was about 6.4 kb
and the signal from the targeted allele was about 8.2 kb (Fig. 1A,B).
Other smaller bands were detectable as well, presumably originating
from the related, intronless copies of 1-cysPrx [8,9]. We screened 471
clones and 16.8% of them were found to contain the targeted 1-cysPrx
allele. Clones 126 and 133 were microinjected into C57BL/6J blasto-
cysts according to the method described by Bradley [13], and embryos
were re-implanted into the uterine horns of foster mothers. A total of
10 chimeric mice were generated. Male chimeras with more than 95%
agouti coat color were chosen to breed with C57BL/6J female mice
(Taconic, Germantown, NY, USA). Germline transmission of the ES
cell chromosome was achieved with chimeric mice derived from both
ES clones. The heterozygous mice containing one inactivated copy of
the 1-cysPrx gene were generated at Wayne State University and all
procedures were approved by the Animal Investigation Committee.
O¡spring that were heterozygous for the mutated 1-cysPrx were
then transferred to the University of Pennsylvania for further breed-
ing and characterization. Animal use was reviewed and approved by
the University of Pennsylvania Animal Care and Use Committee and
mice were cared for in accordance with institutional guidelines. Ho-
mozygous 1-cysPrx knock-out mice were generated by intercross of
the heterozygous knock-out mice. Screening of o¡spring for genotype
(+/+, +/3, or 3/3) was carried out using PCR (Fig. 1C). One reac-
tion ampli¢ed the wild type gene; the other ampli¢ed the targeted
gene. The forward primer for both reactions bound to the 5P portion
of intron 2 that was not deleted in the targeted construct. It had the
sequence 5P-GTCTTGATCTGATCCTTCTGTGGAGTCTGC-3P. The
reverse primer for detecting the wild type gene bound to the portion
of intron 2 that was deleted in the targeting construct. Its sequence
was 5P-GGACTCTGAGAAGCAGTTCCTGGATGTTATC-3P. The
reverse primer for detecting the targeted gene was located in the neo-
mycin resistance cassette. It had the sequence 5P-CACTGAAGCGG-
GAAGGGACTGGC-3P. Mouse tissues were removed after anesthesia
with intraperitoneal pentobarbital sodium (50 mg/kg) and cervical
dislocation, washed with phosphate-bu¡ered saline, snap-frozen in
liquid N2 and stored at 380‡C.
2.3. Preparation of genomic DNA
Genomic DNA from mouse tissue was isolated by using the
QIAamp DNA Mini Kit (Qiagen). Approximately 1 cm of each
mouse tail tip orV20 mg mouse liver tissue was used. Brie£y, tissues
were chopped into small pieces and placed in 180 Wl of bu¡er ATL
and digested by 20 Wl proteinase K (provided with the kit) at 56‡C
overnight or until the tissue was completely lysed. After digestion with
RNase A, 200 Wl bu¡er AL was added and the solution was incubated
at 70‡C for 10 min. Then, 200 Wl 100% ethanol was added to the
sample and the total mixture was applied to a QIAamp spin column.
After washing, the genomic DNA was eluted in 200 Wl bu¡er AE and
stored at 4‡C.
2.4. Isolation of total RNA
Both Trizol Reagent (Life Technologies, Gaithersburg, MD, USA)
and RNeasy Mini Kit (Qiagen) were used to isolate total RNA from
mouse tissues. Brie£y, 50^100 mg of tissue was homogenized in 1 ml
of Trizol Reagent using a glass^Te£on and power homogenizer (Tal-
boys Engineering, Emerson, NJ, USA). After incubation for 5 min at
room temperature, 0.2 ml of chloroform was added per ml of Trizol
Reagent and the solution was mixed vigorously. A colorless upper
aqueous phase was separated after centrifugation and total RNA
was precipitated by mixing with 0.5 ml of isopropyl alcohol per ml
of Trizol Reagent used for the initial homogenization. After washing
with 75% ethanol, the RNA pellet was dissolved in 300 Wl RNase-free
H2O and then re-extracted with an RNeasy Mini Kit using a slightly
modi¢ed protocol. RLT bu¡er (350 Wl) was mixed well with 105 Wl of
the RNA solution. After adding 245 Wl of 100% ethanol, the total
sample was applied to an RNeasy mini column. On-column DNase
digestion was performed by using RNase-free DNase (Qiagen) to re-
move trace genomic DNA. After washing, total RNA was collected in
RNase-free H2O and its concentration was measured by absorbance
at 260 nm with a DU 640B Spectrophotometer (Beckman Coulter,
Fullerton, CA, USA).
2.5. RT-PCR and PCR
RT (reverse transcription)-PCR was performed to check the speci-
¢city of 1-cysPrx and 1-cysPrx-P1 primers and to detect the mRNA
expression of 1-cysPrx and 1-cysPrx-P1 in wild type and 1-cysPrx
knock-out mouse tissues. Brie£y, 1 Wg total RNA was reverse-tran-
scribed into cDNA using a 1st Strand cDNA Synthesis Kit for RT-
PCR (AMV) (Roche). PCR was performed on a Mastercycler (Ep-
pendorf, Westbury, NY, USA) for 33 cycles for both 1-cysPrx and
1-cysPrx-P1. Each cycle included denaturation at 95‡C for 30 s, an-
nealing at 58‡C for 30 s, and elongation at 72‡C for 30 s. The primers
for 1-cysPrx and 1-cysPrx-P1 are shown in Fig. 2A. The size of the
PCR products was determined by 1.2% or 2.2% agarose gel electro-
phoresis with visualization by ethidium bromide staining.
The primers used for obtaining the 1-cysPrx-P1 ORF with a His tag
were: 5P-ATGCCCGGAGGGTTGCTTCTC-3P and 5P-TTA(GTG)6-
AGGCTGGGGTGTATAACGGAGG-3P. The genomic DNA from
mouse liver was used as a template. Pfu Turbo1 DNA Polymerase
(Stratagene) was used to generate an accurate blunt-end PCR prod-
uct. PCR was performed for 40 cycles. Each cycle consisted of dena-
turation at 95‡C for 45 s, annealing at 58‡C for 45 s, and elongation
at 72‡C for 1 min.
2.6. Real-time PCR
To quantify 1-cysPrx and 1-cysPrx-P1 mRNA expression in mouse
tissues, real-time PCR was performed on a LightCycler (Roche) using
a LightCycler-RNA Master SYBR Green I kit (Roche). Brie£y, total
RNA was diluted toV0.1 Wg/Wl. The concentration was measured at
260 nm and the sample was diluted again to a concentration of 50 ng/
8 Wl. Then, 50 ng total RNA from each sample was mixed with 0.3
WM of each primer, 3.0 mM (for 1-cysPrx-P1) or 3.25 mM (for
1-cysPrx and L-actin) Mn(OAc)2, and 1URNA Master SYBR Green
I in a total volume of 20 Wl. The experimental protocol consisted of
¢ve programs: (1) reverse transcription of template RNA at 61‡C for
30 min; (2) denaturation of the cDNA/RNA hybrid at 95‡C for 2 min;
(3) ampli¢cation of cDNA for 45 cycles, each cycle using sequentially
95‡C for 5 s, 58‡C for 10 s and 72‡C for 20 s; (4) analysis of the
melting curve to con¢rm the single product ampli¢cation during
the PCR assay; (5) cooling the rotor and thermal chamber at 40‡C
for 30 s. The primers used for real-time PCR are shown in Fig. 2A.
The primers for mouse L-actin were: 5P-GGCATTGTTACC-
AACTGGGAC-3P and 5P-ACCAGAGGCATACAGGGACAG-3P.
The results were calculated by using the equation: Ratio ¼
ðEtargetÞvCPtargetðcontrolsampleÞ [14]. Etarget is the real-time PCR e⁄ciency
of 1-cysPrx or 1-cysPrx-P1 and vCPtarget is the crossing point (CP)
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deviation of control sample of 1-cysPrx or 1-cysPrx-P1. CP is de¢ned
as the point at which the £uorescence rises appreciably above back-
ground. Standard curves were obtained by real-time PCR using 0.5
ng, 5 ng, and 50 ng total RNA for 1-cysPrx or 1-cysPrx-P1. Real-time
PCR e⁄ciencies were calculated from E=10ð31=slopeÞ using slopes ob-
tained from the standard curves.
2.7. Colony PCR
Colony PCR was performed to select those bacteria containing
vectors with the 1-cysPrx-P1 ORF in the correct orientation. White
colonies on X-gal/IPTG indicator agar plates were picked using 200 Wl
sterile pipet tips and transferred to 1.5 ml Eppendorf tubes containing
25 Wl of sterile water. Bacterial solution (12 Wl) was then transferred to
a 200 Wl PCR tube, which was placed on a Mastercycler (Eppendorf)
at 99‡C for 5 min to lyse the cells and denature DNases. After cen-
trifugation to remove cell debris, 5 Wl of the supernatant was trans-
ferred to a new 200 Wl PCR tube for PCR. PCR was performed on a
Mastercycler (Eppendorf) for 40 cycles, each cycle using sequentially
95‡C for 45 s, 58‡C for 45 s, and 72‡C for 1 min. The forward primer
was in the 1-cysPrx-P1 ORF: 5P-ATGCCCGGAGGGTTGCTTC-
TC-3P. The reverse primer was the pETBlueDOWN primer which is
in the pETBlue-1 vector: 5P-GTTAAATTGCTAACGCAGTCA-3P.
The PCR products were subjected to 1.0% agarose gel electrophoresis
and visualized by ethidium bromide staining.
2.8. Construction of 1-cysPrx-P1 expression vector and in vitro
translation
The 1-cysPrx-P1 ORF was obtained from mouse liver genomic
DNA by PCR as described above and puri¢ed from a 1% agarose
gel by using QIAquick Gel Extraction Kit (Qiagen). The puri¢ed
1-cysPrx-P1 ORF DNA fragment was then inserted into the EcoRV
enzyme site of a bacterial expression vector, pETBlue-1 (Novagen,
Madison, WI, USA) and transformed into Escherichia coli XL-10
Gold ultracompetent cells (Stratagene). The positive bacterial clones
with correct orientation were ¢rst screened by using colony PCR as
described above, then con¢rmed by sequencing using a T7 promoter
primer (5P-TAATACGACTCACTATAGGG-3P) and pETBlue-
DOWN primer (shown above) in the pETBlue-1 vector. The plasmid
DNA containing the correct orientation of the 1-cysPrx-P1 ORF,
isolated by using the Wizard Plus SV Minipreps DNA Puri¢cation
System (Promega), was then transformed into Tuner1 (DE3) pLacI
E. coli expression host cells (Novagen), and a single colony was cul-
tured in Terri¢c Broth (Life Technologies) containing 1% glucose.
When the OD600 of the culture was approximately 0.7, 1-cysPrx-P1
Fig. 1. Targeted disruption of the mouse 1-cysPrx gene. A: Genomic structure and partial restriction map of the mouse 1-cysPrx (Prdx6) locus
(ENSMUSG00000026701, www.ensembl.org) (top), the targeting vector (middle), and the targeted locus (bottom) are shown. The black boxes
represent the protein coding regions in the exons and the open boxes represent the non-coding regions. The exon number is indicated under
each exon. The shaded box on top of the restriction map of the 1-cysPrx locus represents the 3P external sequence used for probing the DNA
blot ¢lters. B, BamHI; E, EcoRI; H, HindIII; N, NotI; X, XhoI; neo, neomycin resistance cassette; TK, herpes thymidine kinase gene. The
neo cassette contained a promoter and polyadenylation site from the mouse phosphoglycerate kinase-1 (PGK-1) gene £anking the neomycin re-
sistance gene. Both neo and TK gene expression were under the control of the mouse PGK-1 promoter located in the neo cassette. The arrow
indicates the orientation of transcription of the neo and TK genes. The sizes of the BamHI restriction fragments from wild type and targeted
loci hybridized with the probe are shown on the top and bottom of the ¢gure, respectively. B: Southern blot analysis of wild type ES cells and
recombinant ES cells carrying mutated 1-cysPrx allele. Genomic DNA isolated from ES cells was digested with BamHI and probed with the 3P
external probe shown in A. +/+ and +/3 represent wild type and heterozygous recombinant ES cells, respectively. The 6.4 kb hybridization
band is derived from the wild type allele, and the 8.2 kb hybridization band from the mutated allele. C: PCR genotyping of mice. Genomic
DNA from mouse tails was screened by PCR as described in Section 2. Panel 1: PCR detection of the intact 1-cysPrx gene was carried out us-
ing a forward primer binding to the portion of intron 2 of the mouse 1-cysPrx gene that is not replaced in the targeting strategy and a reverse
primer that also binds in intron 2 but to a region that is deleted in the targeted locus. Panel 2: PCR detection of the targeted construct was
carried out using the same forward primer as that used for the intact gene while the reverse primer binds in the neomycin resistance cassette
that only exists in the targeted locus. In C^E, +/+, +/3, and 3/3 represent homozygous wild type, heterozygous, and homozygous knock-out
mice, respectively. D,E: Expression of 1-cysPrx in mouse lung. D: 1-cysPrx mRNA expression in mouse lung was measured by real-time PCR
as described in Section 2. The expression level in the lungs of homozygous wild type mice was set to 1. Results are the meanVS.E.M. for
n=3. E: Levels of 1-cysPrx protein in mouse lung. 1-cysPrx protein (10 Wg/lane) from +/+, +/3, and 3/3 mice was analyzed by Western blot
of a reduced gel using the polyclonal anti-peptide antibody to 1-cysPrx.
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protein expression was induced by adding 1 mM IPTG to the culture
medium. After 3 h, bacteria were collected and soluble protein was
extracted with lysis bu¡er (100 mM NaH2PO4, 10 mM Tris^HCl, pH
8.0) followed by treatment with 100 Wg/ml lysozyme and sonication on
ice. Expression of 1-cysPrx-P1 protein was veri¢ed by Simply Blue1
SafeStain (Invitrogen) staining and Western blot. The protein ob-
tained from bacteria without IPTG induction was used as negative
control. Human 1-cysPrx with a C-terminal His tag also was prepared
as described above and used as a positive control [2]. Rat 1-cysPrx
[15] without a His tag was expressed in E. coli.
2.9. Western blot
Mouse tissues were homogenized in lysis bu¡er containing added
protease inhibitors (1 mM phenylmethylsulfonyl £uoride, 10 Wg/ml
aprotinin and 10 Wg/ml leupeptin) followed by sonication on ice. Pro-
tein concentrations were estimated using the Bradford assay (Bio-
Rad, Hercules, CA, USA) using bovine serum albumin as the stan-
dard. Protein samples were subjected to electrophoresis on 12% No-
vex Tris-Glycine Gels (Invitrogen) and transferred to polyvinylidene
£uoride membranes (Millipore, Bedford, MA, USA). For reduced
gels, 2.8 mM L-mercaptoethanol was added to the samples. For block-
ing, membranes were incubated for 1 h or overnight at 4‡C in block-
ing solution, 0.1% Tween 20^TBS bu¡er containing 5% non-fat dry
milk. After washing, the membranes were probed with mouse anti-1-
cysPrx monoclonal antibody, 1:2000, or rabbit anti-1-cysPrx poly-
clonal anti-peptide antibody, 1:3000, followed by horseradish peroxi-
dase-conjugated secondary antibody (Amersham Pharmacia, Piscat-
away, NJ, USA), 1:3000. The monoclonal antibody was generated
against recombinant human protein [15] while the polyclonal anti-
peptide antibody was generated to a synthetic peptide (amino acids
196^211 of the human protein) [6]. The reaction was detected by
chemiluminescence using ECL Western blotting detection reagents
(Amersham Biosciences, Piscataway, NJ, USA) and exposed to
X-Omat AR-2 X-ray ¢lm (Eastman Kodak Company, Rochester,
NY, USA).
3. Results
3.1. Viability of null mice
The mating of mice heterozygous for the 1-cysPrx null allele
produced 17 wild type mice (+/+), 30 heterozygous mice (+/3)
and 16 null mice (3/3), very close to the expected Mendelian
ratio of 1:2:1, indicating that the null mice were viable. The
null mice did not show any obvious physical di¡erences from
their +/+ and +/3 littermates. The level of expression of the
1-cysPrx gene in lungs of heterozygous mice was around 50%
of the level found in homozygous wild type mice as deter-
mined at the mRNA level by real-time PCR (Fig. 1D) and
at the protein level by Western blot (Fig. 1E). Both mRNA
and protein for 1-cysPrx were undetectable in the lungs of the
knock-out mice (Fig. 1D,E). Null mice were mated and pro-
duced litters of null mice, indicating that both null males and
null females were fertile.
3.2. Speci¢city of primers for 1-cysPrx and 1-cysPrx-P1
Speci¢c primers were designed in order to distinguish the
cDNA sequence of 1-cysPrx and 1-cysPrx-P1 by RT-PCR
(Fig. 2A). There are three and ¢ve nucleotide di¡erences in
the forward and reverse primers, respectively. The 248 bp RT-
PCR product for 1-cysPrx contains a TaqI enzyme site that,
when cleaved, results in two bands in the agarose gel, 152 bp
and 96 bp; there is no SmaI enzyme site. In contrast, the 248
bp RT-PCR product for 1-cysPrx-P1 contains a SmaI enzyme
site that, when cleaved, results in two bands, 187 bp and 61
bp; there is no TaqI enzyme site (Fig. 2B). These di¡erences
facilitate the identi¢cation of the two RT-PCR products.
3.3. Expression of 1-cysPrx-P1 and 1-cysPrx in mouse tissues
Tissues obtained from male C57BL/6J mice were used to
measure the expression of 1-cysPrx-P1 and 1-cysPrx by both
real-time PCR and Western blot. The presence of 1-cysPrx
mRNA was detected in all tissues examined including liver,
kidney, heart, testis, brain, seminal gland, skeletal muscle,
spleen, and small intestine with the highest expression level
in lung (Fig. 3A). On the other hand, 1-cysPrx-P1 mRNA was
expressed only in mouse testis (Fig. 3B) with an expression
level that was V25-fold higher than that for 1-cysPrx
(Fig. 3C). Western blot results using the polyclonal anti-pep-
tide antibody showed protein levels consistent with the results
for 1-cysPrx mRNA expression (Fig. 3D).
3.4. Immunoreactivity of recombinant 1-cysPrx-P1
We utilized several antibodies to 1-cysPrx to con¢rm the
pattern of expression in tissues. To determine immunoreactiv-
Fig. 2. Speci¢city of primers for 1-cysPrx and 1-cysPrx-P1. A: Comparison of primer sequences for 1-cysPrx and 1-cysPrx-P1 and restriction
endonuclease sites. The nucleotides that are di¡erent in the two sequences are indicated by a lower case letter and nucleotides that are identical
are indicated by an asterisk. The 1-cysPrx PCR product contains a TaqI enzyme site, but no SmaI enzyme site. The 1-cysPrx-P1 PCR product
contains a SmaI enzyme site, but no TaqI enzyme site. B: Primer-speci¢c PCR products as detected by RT-PCR followed by restriction endo-
nuclease digestion. Lane M, 100 bp DNA ladder (Promega). Lanes 1^3, expression of 1-cysPrx in mouse lung; lanes 4^6, expression of
1-cysPrx-P1 in mouse testis; lanes 1 and 4, no enzyme digestion; lanes 2 and 5, TaqI digestion; lanes 3 and 6, SmaI digestion.
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ity of the antibodies to 1-cysPrx-P1, this protein was synthe-
sized using a bacterial expression vector. Protein synthesis
required IPTG induction (Fig. 4A). The expressed protein
reacted to the anti-1-cysPrx monoclonal antibody (Fig. 4B),
but not to the anti-1-cysPrx polyclonal anti-peptide antibody
(Fig. 4C). The lack of reactivity of the polyclonal anti-peptide
antibody to 1-cysPrx-P1 is consistent with the di¡erence in six
out of the 16 amino acids compared to the human sequence
which was the basis for the immunizing peptide. The wild type
mouse protein had a di¡erence of only two amino acids from
the immunizing peptide which may account for its reactivity
to the antibody. Thus, the immunoblots in Fig. 3D using
polyclonal anti-peptide antibody re£ect only 1-cysPrx while
the monoclonal antibody is required to detect 1-cysPrx-P1
protein.
3.5. Lack of 1-cysPrx-P1 protein expression in 1-cysPrx
knock-out mouse
Analysis of lungs and testis of 1-cysPrx knock-out mice was
used to evaluate whether 1-cysPrx-P1 mRNA generated a
protein in vivo. As expected, the knock-out animals showed
no expression of 1-cysPrx mRNA that was detectable by RT-
PCR (Fig. 5A) or protein that was detectable by Western blot
using either the monoclonal or polyclonal anti-peptide anti-
body (Figs. 1E and 5C). On the other hand, the mRNA level
of 1-cysPrx-P1 in the testis of 1-cysPrx knock-out mice was
not signi¢cantly di¡erent (Ps 0.05) than that for wild type
mice (Fig. 5A,B). Despite the presence of large quantities of
mRNA, protein expression was not detected in the testis of
1-cysPrx knock-out mouse (Fig. 5C). Neither mRNA nor pro-
tein for 1-cysPrx-P1 was detected in the lungs of 1-cysPrx
knock-out mice.
Fig. 3. Expression of 1-cysPrx and 1-cysPrx-P1 in mouse tissues. Expression of 1-cysPrx (A) and 1-cysPrx-P1 (B) was measured by real-time
PCR as described in Section 2. C: Comparison of 1-cysPrx and 1-cysPrx-P1 mRNA levels in mouse lung and testis. In A^C results are
meanVS.E.M. for three mice and the expression level of 1-cysPrx (A,C) or 1-cysPrx-P1 (B) in testis was used as control (ratio= 1). D: Western
blot of mouse tissues from a reduced gel (10 Wg protein per lane) using the polyclonal anti-peptide antibody.
Fig. 4. Immunoreactivity of recombinant 1-cysPrx-P1 protein. For
this analysis, 10 Wg protein was loaded in each lane. A: Expressed
1-cysPrx-P1 recombinant protein stained by Simply Blue SafeStain
(Invitrogen). B,C: Western blot with anti-1-cysPrx monoclonal anti-
body (B) and anti-1-cysPrx polyclonal anti-peptide antibody (C).
Lane M, prestained sodium dodecyl sulfate^polyacrylamide gel elec-
trophoresis standards (Bio-Rad) (A), and MagicMark Western stan-
dards (Invitrogen) (B,C); lane 1, uninduced protein in the absence
of IPTG in the culture medium; lane 2, 1-cysPrx-P1 protein expres-
sion was induced by adding 1 mM IPTG to the culture medium;
lane 3, bacterial expressed human 1-cysPrx with C-terminal His tag
was used as a positive control.
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4. Discussion
Although peroxiredoxins are found in organisms from all
kingdoms, individual proteins have unique properties and tis-
sue and organelle distribution [16]. There are six mammalian
isoforms; 1-cysPrx is the only member that contains one con-
served cysteine residue while other members (Prx I^V) contain
two conserved cysteine residues. 1-cysPrx in rat tissues is ex-
pressed at its highest mRNA and protein levels in the lung
[15^17]. In the present study of mouse tissues, the highest level
of 1-cysPrx expression also was found in the lung. The present
results with real-time PCR are consistent with a previous
analysis of mouse tissue by Northern blot [8]. However, a
report using real-time PCR found that liver was the organ
with the highest 1-cysPrx expression level [18]. This latter re-
port used L-actin mRNA level to normalize the tissue results.
Previous reports have indicated that the liver content of L-ac-
tin is signi¢cantly lower than many other tissues [19,20] and
we have found by real-time PCR of mouse organs (data not
shown) that the lung content of L-actin mRNA is approxi-
mately ¢ve-fold greater than liver content. Thus, normaliza-
tion to L-actin mRNA does not re£ect the true relationship
between liver and lung with respect to the content of 1-cysPrx
mRNA.
As expected, there is no mRNA or protein corresponding to
1-cysPrx in the null mice. In the present study, we investigated
the possible expression of the very similar intronless 1-cysPrx-
P1 gene and whether it could be induced by the absence of
1-cysPrx protein. Our ¢ndings indicate that the mRNA for
this intronless gene in both wild type and knock-out animals
is found only in testis. The ¢ndings in the wild type mouse are
consistent with results of a previous study [21]. To study pos-
sible expression of the protein, we used a monoclonal anti-
body which reacts to expressed recombinant 1-cysPrx-P1 pro-
tein and evaluated the knock-out mouse where there is no
background from the 1-cysPrx gene. Corresponding to the
lack of mRNA, there was no expression of 1-cysPrx-P1 pro-
tein in the lung. Although the protein could have been de-
graded during preparation for Western blot, this is unlikely
since protease inhibitors were used during tissue disruption
and 1-cysPrx was intact. Even in testis where the level of
1-cysPrx-P1 mRNA is much higher than the level of the
1-cysPrx mRNA, we were unable to detect 1-cysPrx-P1 protein.
These results suggest that 1-cysPrx-P1 is an mRNA-ex-
pressed pseudogene that does not result in protein expression
in vivo. Several other genes which express mRNA, but not
protein, have been described and considered as pseudogenes
including human L-threonine 3-dehydrogenase gene [22],
mouse hnRNP A2 pseudogene [23], and mouse Makorin1-
p1 [24]. The presence of messenger RNA for 1-cysPrx-P1
but the absence of protein suggests translational control of
its expression. However, it is possible that 1-cysPrx-P1 protein
is expressed in the testis but rapidly degraded so that its
steady-state tissue content is below the level that can be de-
tected by Western blot.
The highly conserved nature of 1-cysPrx and the ¢nding
that blocking its expression is lethal in at least one cell line
[7] suggested that it might be indispensable for survival. The
data indicate that, at least in mice, knocking out the 1-cysPrx
gene does not grossly compromise development or fertility.
However, the knock-out mice do show signi¢cantly increased
sensitivity to the toxic e¡ects of exposure to 100% O2 (manu-
script in preparation). While these studies were proceeding,
another laboratory knocked out the 1-cysPrx gene using a
di¡erent targeting strategy, obtaining similar results in terms
of mouse viability. The latter mice showed increased sensitiv-
ity to the toxic e¡ects of the herbicide paraquat [18]. Thus,
mice with a knock-out of 1-cysPrx show a phenotype of in-
creased sensitivity to oxidant stress, although they do not
appear to show oxidative lung injury during their initial 3
months of life under unstressed conditions. This result is not
unexpected since there is considerable redundancy of anti-ox-
idant enzymes and a similar lack of e¡ect under unstressed
conditions has been described for knock-out of cytosolic glu-
tathione peroxidase [25,26] and CuZn superoxide dismutase,
although the latter condition did result in altered fertility and
fetal viability [27]. The present study shows that 1-cysPrx-P1
is not required for the compensatory process that protects
mice from oxidant injury under unstressed conditions.
In summary, this study demonstrates in mice that:
(1) 1-cysPrx is expressed in liver, kidney, heart, testis, brain,
seminal gland, skeletal muscle, spleen, and small intestine,
with the highest level of expression in lung; (2) inactivation
of the 1-cysPrx gene is not lethal and does not a¡ect fertil-
ity; (3) 1-cysPrx-P1 mRNA is expressed only in testis ; and (4)
1-cysPrx-P1 protein is not detectable in the testis of 1-cysPrx
knock-out mouse. These data indicate that 1-cysPrx-P1 is an
mRNA-expressed pseudogene.
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Fig. 5. Expression of 1-cysPrx and 1-cysPrx-P1 in wild type and 1-cysPrx knock-out mice. Expression of 1-cysPrx and 1-cysPrx-P1 was studied
by RT-PCR (A), real-time PCR (B), and Western blot (C) in mouse lung and testis as described in Section 2. B: The expression of 1-cysPrx-
P1 in homozygous wild type mice was used as the control (ratio = 1). C: The positive control is bacterially expressed rat 1-cysPrx protein. Each
lane was loaded with 30 Wg protein.
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